Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

NRP-104 given fast track status for treating cocaine dependence

Sep. 3, 2004

Campral receives FDA approval

Aug. 3, 2004

Results of first phase III multicenter study of naltrexone depot formulation

July 22, 2004

Acamprosate does not affect alcohol pharmacokinetics and pharmacodynamics

July 21, 2004

Preliminary data on the effects and safety of TA-NIC in smokers

July 19, 2004

Combined drug therapy reduces cocaine use with limited abuse potential in primates

June 15, 2004

Probuphine completes pilot study for opiate addiction

June 8, 2004

Progress of dopamine D1-selective antagonist lines up milestones for CeNeS

May 28, 2004

ICS-205930 enhances naltrexone-induced suppression of ethanol consumption

May 24, 2004

European Commission broadens Ferriprox indication

May 17, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...